Goldmet Trio 1mg/500mg/0.2mg Tablet SR
Marketer
Uniza Healthcare LLP
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Goldmet Trio 1mg/500mg/0.2mg Tablet SR
Tri-Diabetic 1mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, aiding in the regulation of blood glucose. These tablets should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is a component of a comprehensive treatment plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential for prevention. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Consult your doctor prior to use during pregnancy or breastfeeding. Routine blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Goldmet Trio 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Goldmet Trio 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Goldmet Trio 1mg/500mg/0.2mg SR tablets on an empty stomach.
Common Side effects of Goldmet Trio 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Goldmet Trio 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Goldmet Trio 1mg/500mg/0.2mg Tablet SR whole; do not break, crush, or chew it. Administration should occur on an empty stomach.
How Goldmet Trio 1mg/500mg/0.2mg Tablet SR works:
Each Goldmet Trio SR tablet (1mg/500mg/0.2mg) combines three distinct antidiabetic medications.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Goldmet Trio 1mg/500mg/0.2mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Goldmet Trio 1mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Seek medical advice before taking this medicine.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Goldmet Trio tablets (1mg/500mg/0.2mg) are likely not safe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by abnormally low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Patients with kidney disease should likely avoid Goldmet Trio 1mg/500mg/0.2mg Tablet SR, as its use may be unsafe. Medical advice is recommended. Furthermore, Goldmet Trio 1mg/500mg/0.2mg Tablet SR is contraindicated in individuals with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Goldmet Trio 1mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is recommended. Individuals with mild to moderate liver disease should generally begin with a low dose; however, its use is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Goldmet Trio 1mg/500mg/0.2mg Tablet SR :
Should you forget to take a Goldmet Trio 1mg/500mg/0.2mg Tablet SR, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.
Facts to Know About Goldmet Trio 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
3,018 People bought this recently